Home › Celgene Co. (CELG) Receives New Coverage from Analysts at Standpoint Research
 

Keywords :   


Celgene Co. (CELG) Receives New Coverage from Analysts at Standpoint Research

2016-01-18 00:05:01| Biotech - Topix.net

The firm set a "buy" rating and a $130.00 price target on the biopharmaceutical company's stock. Standpoint Research's price target points to a potential upside of 26.14% from the stock's previous close.

Tags: research coverage receives analysts

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
17.06Potential Tropical Cyclone One Graphics
17.06Potential Tropical Cyclone One Forecast Discussion Number 1
17.06Potential Tropical Cyclone One Wind Speed Probabilities Number 1
17.06Potential Tropical Cyclone One Public Advisory Number 1
17.06Summary for Potential Tropical Cyclone One (AT1/AL012024)
17.06Potential Tropical Cyclone One Forecast Advisory Number 1
17.06New Federal Government Filing Requirement Regarding Ownership of LLCs and Corporations
17.06Manufacturers Reps That Sell to International Customers June 26 Networking Event
More »